Cancer-causing mutations rewire growth signalling in prostate cancer model
Key points:
The PIP3/PI3K signalling pathway is one of the most important signalling mechanisms in our cells, affecting cell metabolism and growth. It is also one of the most frequently altered pathways in human cancer.
Research from the Institute has shown that PI3K pathway remodelling is a common feature of cancers driven by hyperactivated PI3K signalling. Working in prostate tumour models the team identified an unknown activator driving PI3K signalling and cancer growth in a way that is released both from needing positive growth signals and also from growth-limiting feedback controls.
This knowledge identifies new ...
















